Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 19:2024:5595575.
doi: 10.1155/bmri/5595575. eCollection 2024.

Antimicrobial Activity of Tea and Agarwood Leaf Extracts Against Multidrug-Resistant Microbes

Affiliations

Antimicrobial Activity of Tea and Agarwood Leaf Extracts Against Multidrug-Resistant Microbes

Shah Rucksana Akhter Urme et al. Biomed Res Int. .

Abstract

Emerging multidrug-resistant (MDR) strains are the main challenges to the progression of new drug discovery. To diminish infectious disease-causing pathogens, new antibiotics are required while the drying pipeline of potent antibiotics is adding to the severity. Plant secondary metabolites or phytochemicals including alkaloids, phenols, flavonoids, and terpenes have successfully demonstrated their inhibitory potential against the drug-resistant pathogens. In quest of potential phytochemicals, we selected tea (Camellia sinensis) and agarwood (Aquilaria malaccensis) leaves for antimicrobial activity. Fresh tea leaves were collected in three varieties, namely, BT-6, BT-7, and BT-8, including green tea (nonfermented tea), black tea (fully fermented tea), and agarwood leaves collected from Sylhet region of Bangladesh. This study is aimed at analyzing the phytochemical constituency and antimicrobial activity of tea and agarwood leaf extracts and analyzing if there is a combined effect or synergistic activity against multidrug-resistant pathogens. The antimicrobial activity of tea and agarwood leaf extracts was analyzed against MDR pathogenic bacteria and fungus. Qualitative and quantitative phytochemical constituency profiling of these six leaf extracts was evaluated, and preliminary screening exhibited that most of the leaves contained diverse groups of metabolites (alkaloids, tannin, flavonoids, glycosides, saponins, etc.). The highest amounts of TPC (total phenolic content) (110.16 ± 0.48 μg/mg) were found in BT-7 in ethanol extracts, and BT-8 in methanol extracts possessed the highest (128.1 ± 0.43 μg/mg) TFC (total flavonoid content). Notably, green tea showed remarkable results in TPC and TFC. In antioxidant scavenging activity, BT-7 and green tea showed significant IC50 values which were 13.23 and 20.75 mg/mL, respectively. In antimicrobial assays, both 50 μL of each tea and agarwood leaf extract antimicrobial activities were examined against 50 μL of each bacterial and fungal culture. In synergistic activity, 50 μL of each type of leaf extracts was poured over the commercial antibiotics to evaluate their synergism, additive, or antagonism activity against the multidrug-resistant pathogens. In the antimicrobial activity test, green tea showed a maximum diameter (22.0 ± 1.1 mm) zone of inhibition against Klebsiella pneumoniae whereas BT-8 showed 22.0 ± 2.5 mm against Pseudomonas aeruginosa. Indeed, fresh tea BT-6 and BT-7 both showed remarkable zone of inhibition against the selected microbes including Gram-negative and Gram-positive bacteria. Besides, leaf extract also showed antimicrobial activity against pathogenic fungus Mucor circinelloides. Aiming to increase antibiotic resistance efficacy, synergistic activities were evaluated among leaf extracts and antibiotics against the selected pathogens where synergism, antagonism, and additive results were noted. Combination of BT-8 extracts with antibiotics (ceftiofur) showed the highest synergism nearly 36 mm of the zone of inhibition against Escherichia coli. Additionally, green tea with gentamicin and erythromycin also showed remarkable synergism 35 and 33 mm against Mucor circinelloides and E. coli, respectively. Tea and agarwood leaves grown in Bangladesh possess high antioxidant activity, promising antibacterial and antifungal activity, thus might provide a potential source for drug discovery.

Keywords: agarwood leaves; antimicrobial activity; phytochemicals; synergistic activity; tea.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Graphical representation of TPC (total phenolic content) (mean ± SD) of six leaf extracts: BT-8, BT-7, BT-6, BT, GT, and agarwood leaves (AM) (Aquilaria malaccensis).
Figure 2
Figure 2
Graphical representation of TFC (total flavonoid content) (mean ± SD) of six leaf extracts BT-8, BT-7, BT-6, BT, GT, and agarwood leaves (AM) (Aquilaria malaccensis).
Figure 3
Figure 3
IC50 values of tea and agarwood leaf extracts.
Figure 4
Figure 4
Antimicrobial activity of leaves (BT-7, BT-8, BT-6, black tea, green tea, and agarwood) in methanol, ethanol, and chloroform extracts against Salmonella spp., Pseudomonas aeruginosa, Klebsiella pneumoniae, Mucor circinelloides, E. coli, and Staphylococcus aureus.

Similar articles

References

    1. Bennett R. N., Wallsgrove R. M. Secondary metabolites in plant defence mechanisms. New Phytologist . 1994;127(4):617–633. doi: 10.1111/j.1469-8137.1994.tb02968.x. - DOI - PubMed
    1. Friedman M. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Molecular Nutrition & Food Research . 2007;51(1):116–134. doi: 10.1002/mnfr.200600173. - DOI - PMC - PubMed
    1. Fauci A. S., Touchette N. A., Folkers G. K. Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. International Journal of Risk & Safety in Medicine . 2005;11(4):519–525. doi: 10.3201/eid1104.041167. - DOI - PMC - PubMed
    1. Ayukekbong J. A., Ntemgwa M., Atabe A. N. The threat of antimicrobial resistance in developing countries causes and control strategies. Antimicrobial Resistance & Infection Control . 2017;6(1):1–8. doi: 10.1186/s13756-017-0208-x. - DOI - PMC - PubMed
    1. Vlieghe E., Bal A., Gould I. M. Surveillance of antibiotic resistance in developing countries: needs, constraints and realities. In: Sosa A., Byarugaba D., Amábile-Cuevas C., Hsueh P. R., Kariuki S., Okeke I., editors. Antimicrobial Resistance in Developing Countries . New York, NY: Springer; 2010. - DOI

MeSH terms

LinkOut - more resources